KZR KEZAR LIFE SCIENCES INC revenue, earnings and financials
For the quarter ended March 31, 2026, KEZAR LIFE SCIENCES INC reported revenue of n/a, net income of −$5.76M and diluted EPS of −$0.78; for the fiscal year ended December 2025 revenue was $0.
KZR annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$59.1M, net income −$56.0M (margin n/a), EPS −$7.66
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$90.6M, net income −$83.7M (margin n/a), EPS −$11.49
- Fiscal year ended Dec 2023: revenue $7.00M, gross profit n/a, operating income −$111M, net income −$102M (margin -1455.3%), EPS −$14.04
- Fiscal year ended Dec 2022: revenue $0, gross profit n/a, operating income −$71.2M, net income −$68.2M (margin n/a), EPS −$10.13
- Fiscal year ended Dec 2021: revenue $0, gross profit n/a, operating income −$54.7M, net income −$54.6M (margin n/a), EPS −$1.04
KZR quarterly revenue and earnings
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.76M, EPS −$0.78
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$14.5M, EPS −$1.99
- Quarter ended Sep 30, 2025: revenue n/a, net income −$11.2M, EPS −$1.53
- Quarter ended Jun 30, 2025: revenue n/a, net income −$13.7M, EPS −$1.87
- Quarter ended Mar 31, 2025: revenue n/a, net income −$16.6M, EPS −$2.27
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$20.2M, EPS −$2.77
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$20.3M, EPS −$2.78
- Quarter ended Jun 30, 2024: revenue n/a, net income −$21.5M, EPS −$2.96
- Quarter ended Mar 31, 2024: revenue n/a, net income −$21.7M, EPS −$2.98
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$32.3M, EPS −$10.21
- Quarter ended Sep 30, 2023: revenue $7.00M, net income −$23.1M, EPS −$3.18
- Quarter ended Jun 30, 2023: revenue n/a, net income −$24.3M, EPS −$0.34
- Quarter ended Mar 31, 2023: revenue n/a, net income −$22.2M, EPS −$0.31
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$18.2M, EPS −$9.37
- Quarter ended Sep 30, 2022: revenue $0, net income −$17.8M, EPS −$0.25
- Quarter ended Jun 30, 2022: revenue n/a, net income −$16.2M, EPS −$0.25
- Quarter ended Mar 31, 2022: revenue n/a, net income −$16.0M, EPS −$0.26
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$14.2M, EPS −$0.26
- Quarter ended Sep 30, 2021: revenue n/a, net income −$14.5M, EPS −$0.28
- Quarter ended Jun 30, 2021: revenue n/a, net income −$13.0M, EPS −$0.25
KZR cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$51.8M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$74.2M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$81.6M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$58.8M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$42.4M, share buybacks n/a
KZR balance sheet
- Mar 31, 2026: cash $66.2M, total assets $68.0M, total liabilities $2.76M, shareholders' equity $65.2M
- Dec 31, 2025: cash $71.9M, total assets $76.6M, total liabilities $6.57M, shareholders' equity $70.1M, long-term debt $0
- Sep 30, 2025: cash $38.9M, total assets $97.7M, total liabilities $14.8M, shareholders' equity $83.0M, long-term debt $1.37M
- Jun 30, 2025: cash $34.4M, total assets $109M, total liabilities $17.3M, shareholders' equity $91.8M, long-term debt $2.63M
- Mar 31, 2025: cash $37.0M, total assets $125M, total liabilities $22.2M, shareholders' equity $103M, long-term debt $3.87M
- Dec 31, 2024: cash $41.7M, total assets $145M, total liabilities $27.8M, shareholders' equity $117M, long-term debt $5.11M
- Sep 30, 2024: cash $34.9M, total assets $164M, total liabilities $30.0M, shareholders' equity $134M, long-term debt $6.35M
- Jun 30, 2024: cash $28.3M, total assets $180M, total liabilities $29.2M, shareholders' equity $151M, long-term debt $7.59M
What is KZR's revenue?
KEZAR LIFE SCIENCES INC reported $0 of revenue for the fiscal year ended December 2025.
Is KZR profitable?
No. KEZAR LIFE SCIENCES INC lost $45.2M over the last four quarters.
What is KZR's EPS?
Diluted earnings per share over the last four quarters were −$6.17; −$0.78 in the latest quarter.